• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂多糖结合蛋白 (LBP) 可逆转 2 型糖尿病伴心血管合并症患者血浆中纤维蛋白的淀粉样状态。

Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities.

机构信息

Department of Physiological Sciences, Stellenbosch University, Stellenbosch Private Bag X1 MATIELAND, 7602, Stellenbosch, South Africa.

Department of Physiology, Faculty of Health Sciences, University of Pretoria, Arcadia, 0007, South Africa.

出版信息

Sci Rep. 2017 Aug 29;7(1):9680. doi: 10.1038/s41598-017-09860-4.

DOI:10.1038/s41598-017-09860-4
PMID:28851981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5574907/
Abstract

Type 2 diabetes (T2D) has many cardiovascular complications, including a thrombotic propensity. Many such chronic, inflammatory diseases are accompanied (and may be exacerbated, and possibly even largely caused) by amyloid fibril formation. Recognising that there are few strong genetic associations underpinning T2D, but that amyloidogenesis of amylin is closely involved, we have been seeking to understand what might trigger the disease. Serum levels of bacterial lipopolysaccharide are raised in T2D, and we recently showed that fibrin(ogen) polymerisation during blood clotting can be affected strongly by LPS. The selectivity was indicated by the regularisation of clotting by lipopolysaccharide-binding protein (LBP). Since coagulopathies are a hallmark of T2D, we wondered whether they might too be caused by LPS (and reversed by LBP). We show here, using SEM and confocal microscopy, that platelet-poor-plasma from subjects with T2D had a much greater propensity for hypercoagulability and for amyloidogenesis, and that these could both be reversed by LBP. These data imply that coagulopathies are an important feature of T2D, and may be driven by 'hidden' LPS. Given the prevalence of amyloid formation in the sequelae of diabetes, this opens up novel strategies for both the prevention and treatment of T2D.

摘要

2 型糖尿病(T2D)有许多心血管并发症,包括血栓倾向。许多此类慢性炎症性疾病伴随着(并且可能加剧,甚至可能在很大程度上由)淀粉样纤维形成。鉴于 T2D 几乎没有强有力的遗传关联,但胰岛淀粉样肽的淀粉样形成密切相关,我们一直在努力了解可能引发该疾病的原因。T2D 患者的血清细菌脂多糖水平升高,我们最近表明,血液凝固过程中的纤维蛋白(原)聚合可以被脂多糖强烈影响。这种选择性是由脂多糖结合蛋白(LBP)对凝血的正则化所表明的。由于凝血异常是 T2D 的一个标志,我们想知道它们是否也可能由 LPS(并被 LBP 逆转)引起。我们在这里使用 SEM 和共聚焦显微镜显示,来自 T2D 患者的血小板贫血浆具有更高的高凝倾向和淀粉样形成倾向,而这些都可以被 LBP 逆转。这些数据表明凝血异常是 T2D 的一个重要特征,并且可能由“隐藏”的 LPS 驱动。鉴于糖尿病后遗症中淀粉样形成的普遍性,这为 T2D 的预防和治疗开辟了新的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/be7db36a849a/41598_2017_9860_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/7d6918ed31e4/41598_2017_9860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/f3a44071a9fb/41598_2017_9860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/4f06c789995e/41598_2017_9860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/63a05a2daeb1/41598_2017_9860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/8a58e9315b5c/41598_2017_9860_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/69fec394dc6c/41598_2017_9860_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/00b147cfaa70/41598_2017_9860_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/2577c9a60f06/41598_2017_9860_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/b86b6dcb2950/41598_2017_9860_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/be7db36a849a/41598_2017_9860_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/7d6918ed31e4/41598_2017_9860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/f3a44071a9fb/41598_2017_9860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/4f06c789995e/41598_2017_9860_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/63a05a2daeb1/41598_2017_9860_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/8a58e9315b5c/41598_2017_9860_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/69fec394dc6c/41598_2017_9860_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/00b147cfaa70/41598_2017_9860_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/2577c9a60f06/41598_2017_9860_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/b86b6dcb2950/41598_2017_9860_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3064/5574907/be7db36a849a/41598_2017_9860_Fig10_HTML.jpg

相似文献

1
Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities.脂多糖结合蛋白 (LBP) 可逆转 2 型糖尿病伴心血管合并症患者血浆中纤维蛋白的淀粉样状态。
Sci Rep. 2017 Aug 29;7(1):9680. doi: 10.1038/s41598-017-09860-4.
2
Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains.使用淀粉样蛋白选择性荧光染色评估 2 型糖尿病中的大量纤维蛋白淀粉样变性。
Cardiovasc Diabetol. 2017 Nov 2;16(1):141. doi: 10.1186/s12933-017-0624-5.
3
Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.脂多糖结合蛋白 (LBP) 可逆转帕金森病中观察到或诱导的纤维蛋白的淀粉样状态。
PLoS One. 2018 Mar 1;13(3):e0192121. doi: 10.1371/journal.pone.0192121. eCollection 2018.
4
Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's Disease, Alzheimer's Disease and Type 2 Diabetes Mellitus.相关光电子显微镜检测到脂多糖及其与帕金森病、阿尔茨海默病和 2 型糖尿病的纤维蛋白纤维的关联。
Sci Rep. 2018 Nov 14;8(1):16798. doi: 10.1038/s41598-018-35009-y.
5
Lipopolysaccharide-binding protein is bound and internalized by host cells and colocalizes with LPS in the cytoplasm: Implications for a role of LBP in intracellular LPS-signaling.脂多糖结合蛋白被宿主细胞结合并内化,且在细胞质中与脂多糖共定位:对脂多糖结合蛋白在细胞内脂多糖信号传导中作用的启示。
Biochim Biophys Acta. 2016 Apr;1863(4):660-72. doi: 10.1016/j.bbamcr.2016.01.015. Epub 2016 Jan 22.
6
Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.通过对高度亚化学计量水平的细菌脂多糖进行分子扩增急性诱导异常和淀粉样蛋白生成性血液凝固。
J R Soc Interface. 2016 Sep;13(122). doi: 10.1098/rsif.2016.0539.
7
Liver transplantation and inflammation: is lipopolysaccharide binding protein the link?肝移植与炎症:脂多糖结合蛋白是否为其中的关联?
Cytokine. 2013 Oct;64(1):71-8. doi: 10.1016/j.cyto.2013.07.025. Epub 2013 Aug 16.
8
The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia.脂多糖结合蛋白逆转阿尔茨海默病型痴呆患者血浆纤维蛋白中淀粉样蛋白形成的潜力。
Front Aging Neurosci. 2018 Aug 22;10:257. doi: 10.3389/fnagi.2018.00257. eCollection 2018.
9
Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.脂多糖结合蛋白与2型糖尿病患者的动脉僵硬度相关:一项横断面研究。
Cardiovasc Diabetol. 2017 May 10;16(1):62. doi: 10.1186/s12933-017-0545-3.
10
Lipopolysaccharide-binding protein is increased in patients with psoriasis with metabolic syndrome, and correlates with C-reactive protein.脂多糖结合蛋白在伴有代谢综合征的银屑病患者中增加,并与 C 反应蛋白相关。
Clin Exp Dermatol. 2013 Jan;38(1):81-4. doi: 10.1111/ced.12007. Epub 2012 Oct 22.

引用本文的文献

1
A Direct Relationship Between 'Blood Stasis' and Fibrinaloid Microclots in Chronic, Inflammatory, and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment.慢性炎症性和血管性疾病中“血瘀”与类纤维蛋白微血栓的直接关系及一些传统天然产物治疗方法
Pharmaceuticals (Basel). 2025 May 12;18(5):712. doi: 10.3390/ph18050712.
2
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities.2型糖尿病及相关合并症多基因风险背后的血浆蛋白质组学标志物的鉴定
Nat Commun. 2025 Mar 3;16(1):2124. doi: 10.1038/s41467-025-56695-z.
3
The Proteome Content of Blood Clots Observed Under Different Conditions: Successful Role in Predicting Clot Amyloid(ogenicity).

本文引用的文献

1
To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?纤维蛋白的朊病毒/淀粉样形式是否在多大程度上真正驱动了脓毒症、感染性休克、全身炎症反应综合征和多器官功能障碍综合征的终末期?
Semin Thromb Hemost. 2018 Apr;44(3):224-238. doi: 10.1055/s-0037-1604108. Epub 2017 Aug 4.
2
A Dormant Microbial Component in the Development of Preeclampsia.子痫前期发展过程中的一种潜伏微生物成分。
Front Med (Lausanne). 2016 Nov 29;3:60. doi: 10.3389/fmed.2016.00060. eCollection 2016.
3
Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.
不同条件下观察到的血凝块蛋白质组含量:在预测血凝块淀粉样变性方面的成功作用。
Molecules. 2025 Feb 3;30(3):668. doi: 10.3390/molecules30030668.
4
Fibrinaloid Microclots and Atrial Fibrillation.纤维蛋白样微血栓与心房颤动
Biomedicines. 2024 Apr 17;12(4):891. doi: 10.3390/biomedicines12040891.
5
Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID.纤维蛋白样微凝块在体位性直立性心动过速综合征(POTS)中的可能作用:关注长期新冠症状
J Pers Med. 2024 Jan 31;14(2):170. doi: 10.3390/jpm14020170.
6
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity.脂多糖结合蛋白(LBP)水平降低与人类肥胖中的非酒精性脂肪性肝病(NAFLD)和脂肪炎症有关。
Int J Mol Sci. 2023 Dec 6;24(24):17174. doi: 10.3390/ijms242417174.
7
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system.长新冠/COVID-19 后急性后遗症(PASC)中纤维蛋白原纤维微血栓的蛋白质组学研究表明,其中有许多被捕获的促炎分子,这也可能导致纤溶系统失效。
Cardiovasc Diabetol. 2022 Sep 21;21(1):190. doi: 10.1186/s12933-022-01623-4.
8
The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.缺血再灌注损伤在类风湿性关节炎、长新冠和 ME/CFS 等慢性、复发性疾病中的潜在作用:证据、机制和治疗意义。
Biochem J. 2022 Aug 31;479(16):1653-1708. doi: 10.1042/BCJ20220154.
9
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).长新冠/COVID-19 后急性后遗症(PASC)患者的症状、合并症、纤维蛋白淀粉样微栓和血小板病理的流行情况。
Cardiovasc Diabetol. 2022 Aug 6;21(1):148. doi: 10.1186/s12933-022-01579-5.
10
Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies.血浆脂多糖结合蛋白是未来静脉血栓栓塞的生物标志物:来自发现和验证研究的结果。
J Intern Med. 2022 Sep;292(3):523-535. doi: 10.1111/joim.13502. Epub 2022 Apr 27.
细菌成分在类风湿性关节炎及其伴随的氧化应激、全身炎症和高凝状态中起主要作用。
Exp Biol Med (Maywood). 2017 Feb;242(4):355-373. doi: 10.1177/1535370216681549. Epub 2016 Nov 26.
4
Cell-specific increased expression of calpastatin prevents diabetes induced by islet amyloid polypeptide toxicity.胰岛淀粉样多肽毒性导致的糖尿病可以通过组织特异性增强钙蛋白酶抑制蛋白的表达来预防。
JCI Insight. 2016 Nov 3;1(18):e89590. doi: 10.1172/jci.insight.89590.
5
Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk.糖尿病前期最新进展:聚焦诊断标准与心血管风险。
World J Diabetes. 2016 Oct 15;7(18):423-432. doi: 10.4239/wjd.v7.i18.423.
6
Diabetes and Clinical and Subclinical CVD.糖尿病与临床及亚临床心血管疾病
Glob Heart. 2016 Sep;11(3):337-342. doi: 10.1016/j.gheart.2016.07.005.
7
Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes.肠道菌群失调、肠道通透性增加与细菌易位:抑郁症、肥胖症和2型糖尿病之间缺失的环节
Curr Pharm Des. 2016;22(40):6087-6106. doi: 10.2174/1381612822666160922165706.
8
Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.通过对高度亚化学计量水平的细菌脂多糖进行分子扩增急性诱导异常和淀粉样蛋白生成性血液凝固。
J R Soc Interface. 2016 Sep;13(122). doi: 10.1098/rsif.2016.0539.
9
Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting.行为异常的蛋白质。亚化学计量分子对淀粉样纤维形成起始和性质的控制与放大:来自血液凝固并应用于血液凝固的经验教训
Prog Biophys Mol Biol. 2017 Jan;123:16-41. doi: 10.1016/j.pbiomolbio.2016.08.006. Epub 2016 Aug 21.
10
Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.血清淀粉样蛋白A与糖尿病肾病患者的死亡风险及终末期肾病
J Diabetes Complications. 2016 Nov-Dec;30(8):1467-1472. doi: 10.1016/j.jdiacomp.2016.07.018. Epub 2016 Jul 27.